P. Dickinson

Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study

Anastasia Chalkidou, Thomas Macmillan, Mariusz Grzeda et al. · The Lancet Oncology · 2020 · 237 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings

T. M. A. Abdel-Fatah, Christina J. Perry, P. Dickinson et al. · Annals of Oncology · 2013 · 88 citations · Full text

Medicine, Cancer Biology, Oncology +16

Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer

A.S. Dhadda, P. Dickinson, Abed M. Zaitoun et al. · European Journal of Cancer · 2011 · 81 citations

Medicine, Oncology, Surgery +13

Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) – An analysis of UK’s largest cohort of lung SABR patients

Animesh Saha, Matthew Beasley, N. Hatton et al. · Radiotherapy and Oncology · 2020 · 50 citations

Medicine, Oncology, Radiation Oncology +17

Mandard Tumour Regression Grade, Perineural Invasion, Circumferential Resection Margin and Post-chemoradiation Nodal Status Strongly Predict Outcome in Locally Advanced Rectal Cancer Treated with Preoperative Chemoradiotherapy

A.S. Dhadda, E.M. Bessell, J H Scholefield et al. · Clinical Oncology · 2014 · 37 citations · Full text

Medicine, Oncology, Surgery +17